Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Taubert medicin AB
AB
Active
Org 5590211883
Lupingränd 17
General medical practice activities · NACE 8621
Est. 2015
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 404K
-78% vs 2024
EBITDA margin
0.2%
-100% vs 2024
Equity ratio
56.0%
Financial strength
Net profit 2025
SEK -214
-100% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 404K
-78%
EBITDA
SEK 644
-100%
Net profit
SEK -214
-100%
Total assets
SEK 97K
-77%
Equity
SEK 54K
-67%
Employees
1
—
Company information
Legal name
Taubert medicin AB
Org number
5590211883
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 juli 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Verksamhet för bolaget är att sälja vård och omsorgstjänster som utövande läkare samt därmed förenlig verksamhet.
Contact
Address
Lupingränd 17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Tyresö
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2021
0M
2022
1M
2023
2M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
272
202
1 055
1 859
404
Staff expenses
—
−208
−876
−1 535
−338
EBITDA
208
−74
34
130
1
Depreciation & amort.
−0
—
—
—
—
EBIT
208
−74
34
130
1
Net financials
−1
—
−0
−0
−1
Profit before tax
208
−74
33
130
−0
Tax
−21
—
—
−19
−0
Net profit
187
−74
33
111
−0
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
233
129
293
421
97
Equity
176
30
63
164
54
Long-term debt
0
—
18
6
0
Short-term debt
57
99
213
250
43
Total debt
57
99
230
256
43
Financial ratios
5-year trend
EBITDA margin
0.2%
This company
15.8%
Market median
-99% vs market
2021
2025
Equity ratio
56.0%
This company
38.2%
Market median
+47% vs market
2021
2025
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
2021
2025
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
2021
2025
Asset turnover
4.17×
This company
1.12×
Market median
+272% vs market
2021
2025
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
YS
Yvonne Sternberg Taubert
Deputy Board Member
2021
BE
Björn Erik Taubert
Board of Directors
2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Taubert medicin AB also hold positions in
0
other companies.
Person
Role here
Other companies
Yvonne Sternberg Taubert
Deputy Board Member
0 companies
Björn Erik Taubert
Board of Directors
0 companies